Newsletter

Phthalates in medical devices: call for evidence

Phthalates in medical devices: call for evidence

The Scientific Committee for Health, Environment and Emerging Risks (SCHEER) has received a request to update the guidelines for the risk-benefit assessment of the presence of phthalates in certain medical devices to also include carcinogenic, mutagenic, toxic phthalates for reproduction (CMR) or having endocrine disrupting properties.

Cookie Policy
Manage Cookies
Cookies help us remember you, personalize your experience, deliver personalized commercial offers and show you more things we think you will like. For more information on cookies, please visit our cookie policy page.
Privacy Settings
These cookies enable us to offer you a personalized experience based on your navigation: